1. Dr Parthasarathy S
Pg Resident,MS Orthopaedics
Stanley Medical College,Chennai
Ref:Rockwood and Green’s fractures in adults 8th
edition
2. Fractures occuring in abnormal weakened
bone during normal activity or after minor
trauma
Many of these patients have additional
fractures,delayed union or nonunion
5. Major health problem for 55% of people >50
years
80% affected by osteoporosis are women
Patients >50 yrs of age who sustain a hip
fracture 24% will die within in a year
One of every two women will have an
osteoporosis related fracture in her lifetime
Spine,proximal femur,distal femur,distal
radius common locations for pathologic
fracture
6. 50% of tumours can metastasize to skeleton
Mainly originates from
breast
lung
prostate
hyroid
kidney
Common sites of metastasis
Spine
Pelvis
Ribs
Skull
Proximal femur
Proximal humerus
7.
8.
9.
10. Osteoporosis in x-rays
Thin cortex
Loss of normal trabecular pattern
Osteomalacia/Hyperparathyroidism in x-rays
Looser lines(compression side radiolucent lines)
Calcification of small vessels
Phalangeal periosteal reaction
11. Parrish and Murray, 1970
increasing pain with advancing cortical destruction of
lesions involving >50% of the shaft diameter
Beals, 1971
lesions >2.5 cm are at increased risk to fracture
Murray, 1974
increased fracture with destruction of > one-third of
the cortex, pain after radiotherapy
12. Fidler, 1981
% shaft destroyed Incidence Fx (%)
0-25% 0%
25-50% 3.7%
50-75% 61%
>75% 79%
Conclusion: Patients with tumors destroying
>50% of the diameter of bone require
prophylactic internal fixation
13. Score < 7 no surgery
Score > 7 prophylactic fixation
14. “Harrington criteria”
>50% of diameter of bone
>2.5 cm
pain after radiation
fracture of the lesser trochanter
Limitations
only for proximal femur
doesn’t account for tumor biology
15. Osteoporosis
insufficiency fractures
Paget’s disease
early and late stages; most fractures occur in the
late stage of disease
Hyperparathyroidism
dissecting osteitis
fractures through Brown tumors
Fractures through non-neoplastic bone disease
17. Adenoma
Polyostotic disease
Mental status changes
Abdominal pain
Nephrolithiasis
Polyostotic disease
mixed radiolucent/radiodense
Mixed
radiodense
and
radiolucent
lesions
Multiple brown tumors
in a patient with primary
hyperparathyroidism
18. May be secondary to renal
failure
secondary
tertiary
Treatment
parathyroid adenectomy
ORIF for fracture
correct calcium
Pathologic fracture through
brown tumor (arrow)
19. Fractures more common in benign tumors (vs
malignant tumors)
most asymptomatic prior to fracture
antecedent nocturnal/rest symptoms rare
most common in children
humerus
femur
unicameral bone cyst, NOF, fibrous dysplasia,
eosinophilic granuloma
20. Fractures observed more
often in males than females
May be active or latent
Almost always solitary
First two decades
Humerus and femur most common
sites
Fracture through UBC
“fallen fragment”sign (arrow)
Fractures through benign tumors
21. Treatment - impending fractures
observation
aspiration and injection methylprednisolone,
bone marrow or bone graft
curetting and bone graft (+/-) internal fixation
Treatment - fractures
allow fracture to heal and reassess
ORIF for femoral neck fractures
22. Most common benign tumor
Femur, distal tibia, humerus
Multiple in 8% of patients
(associated
with
neurofibromatosis)
Increased risk of pathologic
fracture in
lesions >50%
diameter of bone and
>22mm
length
23. Treatment
observation
curetting and bone graft for impending fractures
immobilization and reassess after healing for
patients with fracture
24. Solitary vs. multifocal (solitary
most common)
Femur and humerus
First and second decades
May be associated with café
au lait spots and endocrinopathy
(Albright’s syndrome)
25. Treatment
observation
curetting and bone graft (cortical structural
allograft) to prevent deformity and fracture
(+/-) internal fixation/replacement arthroplasty
expect resorption of graft and recurrence
pharmacologic—bisphosphonates
26. Relatively rare (often unsuspected)
May occur prior to or during treatment
May occur later in patients with radiation
osteonecrosis (Ewing’s, lymphoma)
Osteosarcoma, Ewing’s, malignant fibrous
histiocytoma, fibrosarcoma
27. Suspect primary tumor in younger patients
with aggressive appearing lesions
poorly defined margins (wide zone of transition,
lack of sclerotic rim)
matrix production
periosteal reaction
Patients usually have antecedent pain before
fracture, especially night pain
28. Pathologic fracture complicates but does not
mitigate against limb salvage
Local recurrence is higher
Survival is not compromised
Patients with fractures and underlying
suspicious lesions or history should be
referred for biopsy
29. A
B
A. Pathologic fracture through MFH
arising in antecedent infarct
B. (H&E 100x) Pleomorphic spindled
cells with storiform growth pattern
30. Always biopsy solitary destructive bone
lesions even with a history of primary
carcinoma
31. Pre-op Post-
Intermediate grade chondrosarcoma
*fixation of primary bone tumors must not be performed until proper
evaluation has been performed and the diagnosis has been established in
order to prevent potential for spread of tumor.
33. Aside from osteoporosis, most common
causes of pathologic fracture
Fifth decade and beyond
Appendicular sites: femur and humerus most
common
All metastatic tumors are not treated the
same
36. Release of cells from the
primary tumor
Invasion of efferent lymphatic or
vascular channels
Dissemination of cells
Endothelial attachment and
invasion at distant site
Angiogenesis and tumor growth
at distant site
Metastatic carcinoma
In body pedicle junction
37. Early
most important
osteoclast mediated
(RANK L)
Late
malignant cells may be directly
responsible
38. 3-4% of all carcinomas have no known primary
site
10-15% of these patients have bone metastases
41. Overall 85% response rate
Median duration of pain relief 12-15 weeks
Tumor necrosis followed by collagen
proliferation, woven bone formation, and
replacement by lamellar bone
Recalcification by 2-3 months
More than half respond within 1-2 weeks
Various dose and fractionization schedules
42. Competitive inhibitor of RANKL receptor
Decrease in the time to skeletal related events as
well as decrease in the rate of these events in
patients with bone metastasis
Osteoporosis
Bone pain & hypercalcemia
43. Decrease pain
Restore function
Maintain/restore mobility
Limit surgical procedures
Minimize hospital time
Early return to function (immediate
weightbearing)
44. Biopsy especially for solitary lesions
Nails versus plates versus arthroplasty
plates, screws and cement superior for torsional
loads
interlocked nails stabilize entire bone
Cement augmentation
Radiation/chemotherapy/bisphosphonates
Aggressive rehabilitation
45. Ratio of survival time to surgical recovery
time
Ability to ambulate
Ability to use extremity
Capacity to return to full function
Pain not controlled by analgesics
Location of disease – high risk area
46. Diaphyseal lesion
Good bone stock
Histology sensitive to
chemo/radiation
Impending fractures
Poor prosthetic options
48. Periarticular fractures, especially around
the hip are more appropriately treated
with arthroplasty
Periacetabular fractures
protrusio shell,
cement, arthroplasty
saddle prosthesis
Structural
allograft-prosthesis
composite
56. Any process that reduces bone strength predisposes
a patient to a pathologic fracture during normal
activity or after minimal trauma.
It must be recognized as a pathologic fracture if the
patient is to be treated properly.
The most common cause for a pathologic fracture is
osteoporosis or osteomalacia.
Patients with osteoporosis or osteomalacia require
evaluation and management of the underlying
disorder.
Patients older than 40 years of age with a pathologic
fracture through a discrete bone lesion are much
more likely to have metastatic bone disease than a
primary bone tumor.
57. The prognosis for patients with metastatic
bone disease is improving because of early
recognition and better adjuvant treatment;
therefore, many patients will live longer
than 2 years.
Do not immediately assume that a lytic
lesion or pathologic fracture is from
metastatic disease. A thorough workup and
possible biopsy are required.
Prophylactic fixation for impending (vs.
actual) fractures from metastatic disease is
technically easier for the surgeon and allows
a quicker patient recovery.
The Mirels’s scoring system is available to
guide the treatment of an impending
fracture from metastatic bone disease.
58. Femoral neck fractures caused by metastatic
bone disease require a cemented hip
prosthesis, as internal fixation has a high
rate of failure with disease progression.
An isolated fracture of the lesser trochanter
is usually a sign of a metastatic femoral neck
lesion with impending fracture.
When surgery is required for metastatic
disease to the spine, decompression and
stabilization with internal fixation are
generally necessary.
Surgical reconstruction for pathologic
fractures should be durable enough to allow
immediate weight bearing and last the
patient’s expected life span.
59. A pathologic fracture through a primary
malignant bone tumor is treated much
differently than a fracture through a
metastatic lesion.
The treating surgeon should keep in mind
with proper surgery there is a chance for
long-term cure.
Treatment of patients with pathologic
fractures requires the presence of a
multidisciplinary team comprises orthopedic
surgeons, medical oncologists, radiation
oncologists,endocrinologists, radiologists,
pathologists, pain specialists, nutritionists,
physical therapists, and psychologists/
psychiatrists.